
Eisai (TYO: 4523) and Ajinomoto Co. (TYO: 2802) have announced an agreement to establish a new gastrointestinal speciality pharmaceutical company, …
Japanese drugmaker Ajinomoto has agreed to acquire Althea Technologies, a provider of biopharmaceutical development and manufacturing services, for an estimated …
Scots neonatal innovations target hearing loss and earlier care
Agentis Health Group acquires Clinical Pharmacist Solutions

